Search research articles
Contact Us
Filters
Showing results (71-80 of 110) with videos related to
Page
of 11
Sort By:
Scientific Reports
|
May 16, 2024
The miR-641-STIM1 and SATB1 axes play important roles in the regulation of the Th17/Treg balance in ITP
Hongkai Zhu, Xueqin Ruan, Kexin Zhao, et al.
Journal of Ovarian Research
|
December 21, 2021
The prognostic factor for recurrence in advanced-stage high-grade serous ovarian cancer after complete clinical remission: a nested case-control study
Qiao Wang, Ying Zheng, Ping Wang, et al.
Scientific Reports
|
July 13, 2022
Proteomic profiling of plasma exosomes from patients with B-cell acute lymphoblastic leukemia
Shicong Zhu, Cheng Xing, Ruijuan Li, et al.
Clinical and Experimental Medicine
|
May 8, 2024
Enhancing multiple myeloma staging: a novel cell death risk model approach
Zeyu Deng, Hongkai Zhu, Zhaoshun Yuan, et al.
Frontiers in Immunology
|
March 27, 2023
Case report: Targeting the PD-1 receptor and genetic mutations validated in primary histiocytic sarcoma with hemophagocytic lymphohistiocytosis
Yan Zhao, Yating Deng, Yi Jiang, et al.
Human Cell
|
May 24, 2023
HDAC inhibitor chidamide overcomes drug resistance in chronic myeloid leukemia with the T315i mutation through the Akt-autophagy pathway
Le Yin, Qingyang Zhang, Sisi Xie, et al.
Oncotarget
|
April 14, 2015
Icaritin suppresses multiple myeloma, by inhibiting IL-6/JAK2/STAT3
Shicong Zhu, Zhihua Wang, Zijian Li, et al.
Blood Advances
|
September 27, 2023
Application of R2-ISS risk stratification to patients with multiple myeloma treated with autologous stem cell transplants at UAMS
Wancheng Guo, Anne Zhan, David E Mery, et al.
Gene
|
January 9, 2022
Identification of diagnosis and prognosis gene markers in B-ALL with ETV6-RUNX1 fusion by integrated bioinformatics analysis
Hongkai Zhu, Rong Zhang, Ruijuan Li, et al.
Cancer Cell International
|
April 18, 2019
RNF8 is responsible for ATRA resistance in variant acute promyelocytic leukemia with GTF2I/RARA fusion, and inhibition of the ubiquitin-proteasome pathway contributes to the reversion of ATRA resistance
Wenzhe Yan, Ji Li, Yang Zhang, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 110) with videos related to
Sort By:
Page
of 11
Scientific Reports
|
May 16, 2024
The miR-641-STIM1 and SATB1 axes play important roles in the regulation of the Th17/Treg balance in ITP
Hongkai Zhu, Xueqin Ruan, Kexin Zhao, et al.
Journal of Ovarian Research
|
December 21, 2021
The prognostic factor for recurrence in advanced-stage high-grade serous ovarian cancer after complete clinical remission: a nested case-control study
Qiao Wang, Ying Zheng, Ping Wang, et al.
Scientific Reports
|
July 13, 2022
Proteomic profiling of plasma exosomes from patients with B-cell acute lymphoblastic leukemia
Shicong Zhu, Cheng Xing, Ruijuan Li, et al.
Clinical and Experimental Medicine
|
May 8, 2024
Enhancing multiple myeloma staging: a novel cell death risk model approach
Zeyu Deng, Hongkai Zhu, Zhaoshun Yuan, et al.
Frontiers in Immunology
|
March 27, 2023
Case report: Targeting the PD-1 receptor and genetic mutations validated in primary histiocytic sarcoma with hemophagocytic lymphohistiocytosis
Yan Zhao, Yating Deng, Yi Jiang, et al.
Human Cell
|
May 24, 2023
HDAC inhibitor chidamide overcomes drug resistance in chronic myeloid leukemia with the T315i mutation through the Akt-autophagy pathway
Le Yin, Qingyang Zhang, Sisi Xie, et al.
Oncotarget
|
April 14, 2015
Icaritin suppresses multiple myeloma, by inhibiting IL-6/JAK2/STAT3
Shicong Zhu, Zhihua Wang, Zijian Li, et al.
Blood Advances
|
September 27, 2023
Application of R2-ISS risk stratification to patients with multiple myeloma treated with autologous stem cell transplants at UAMS
Wancheng Guo, Anne Zhan, David E Mery, et al.
Gene
|
January 9, 2022
Identification of diagnosis and prognosis gene markers in B-ALL with ETV6-RUNX1 fusion by integrated bioinformatics analysis
Hongkai Zhu, Rong Zhang, Ruijuan Li, et al.
Cancer Cell International
|
April 18, 2019
RNF8 is responsible for ATRA resistance in variant acute promyelocytic leukemia with GTF2I/RARA fusion, and inhibition of the ubiquitin-proteasome pathway contributes to the reversion of ATRA resistance
Wenzhe Yan, Ji Li, Yang Zhang, et al.
Page
of 11